+467.0%
MRNA vs NIO
-36.7%
+503.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.1% | +2.3% | +4.6% |
| 7D | -1.1% | -2.9% | +1.8% | -0.4% |
| 30D | +126.1% | -18.7% | +144.8% | +138.4% |
| 3M | +190.0% | -29.4% | +219.5% | +210.8% |
| 6M | +157.2% | -32.5% | +189.8% | +175.7% |
| YTD | +388.2% | -27.6% | +415.8% | +414.3% |
| 1Y | +467.0% | -39.2% | +506.2% | +510.3% |
| All | +467.0% | -36.7% | +503.7% | +510.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NIO.
Daily Out/Under-Performance
Portfolio return minus NIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling